In about two thirds of the currently used vaccines for babies, Young people and adults are active amplifier (adjuvants). They are (for example, the last in Europe offered swine flu vaccines), especially aluminum, in rarer cases, squalene compounds. A number of novel adjuvants is currently in the various test stages.
The currently approved active amplifier cause inflammation at the injection site, thus providing an alert of the immune system. Without these active booster vaccination, most would not work or much worse. Without active amplifiers would be the formation of antibodies, after which the effect of most vaccines is measured, or not less available.
We know from numerous studies, that very active amplifiers are mainly responsible for pain and swelling at the injection site and the cause for vaccinations frequent systemic reactions such as fever, etc..
caused by the mainly on the active amplifier triggered immune response in all subjects - in addition to the desired formation of antigen-specific cells of the immune system - even auto-aggressive T-or B-cells and antibodies that attach themselves to body's cells and use them as false "foreign "and" dangerous "mark and thus provide for the immunity-free as targets. One of the mechanisms responsible for this is " molecular mimicry "-.. this refers to mix-up processes at the molecular level
autoaggressive cells are usually identified by the self-protection mechanisms of the immune system and rendered harmless, if failed in susceptible people, this mechanism can, however, the formation of permanent autoimmune disorders lead. either immediately after inoculation or as a gradual process with a time delay.
aluminum compounds for more than 70 years used in vaccines. They are regarded as "Dirty Little Secret" of immunology, because the longest time was completely unknown, how do they work in practice. Only in the last ten years, we here explain some mechanisms can. Then you know as well, that the alert expires at the destruction of the immune system cells at the injection site, destroyed by these cells release uric acid as an internal alarm signal, which then call mass immune cells to the injection site. Those who want to learn more about the effects, I recommend the article "The immune biology of aluminum adjuvants: how do they really work " is published in March 2010 in the journal Trends in Immunology .
is
While on the one hand, at last begun to elucidate the biological mechanisms of the old aluminum adjuvants, the industry is already casting novel reinforced aluminum compounds on the market.
you first came into Gardasil and Cervarix, the two vaccines against human papillomavirus (HPV) for girls from 12 years in the mass use. This new type of aluminum compounds are called the product Cervarix of GlaxoSmithKline (GSK) " AS04 " (" adjuvant system 04 ") and the market leader Gardasil of Sanofi Pasteur MSD " AAHS ( "amorphous aluminum sulfate hydroxyphosphate").
AAHS is different - according to company own research report - both in structure and significantly, by the function of the previously used aluminum salts and was chosen specifically because of its considerably increased immunogenic properties for HPV vaccination.
still new and in its original composition is the AS04 active amplifier. GSK relies on the alarm potential of a fat content, which was recovered from the surface of Salmonella and combines it with aluminum hydroxide. In direct comparison with Gardasil showed that AS04 is actually an explosive combination and a be two to six times higher produced antibody titers in the vaccinees.
But we come now to the core issue: How
tested this novel mode amplifier?
I asked Hugues Bogaerts , Cervarix for the product manager of the Belgian Group for the GSK-safety trials for its novel adjuvant that has so far been used yet in any mass vaccine. His answer was: "My safety studies in humans are not provided with a new adjuvant. This is tested in large clinical trials like in the finished vaccine combination. "
How here 've repeatedly criticized was in the large studies (40,000 participants) on Gardasil and Cervarix but also in the control groups aluminum-containing active amplifiers used in Gardasil even completely the same as contained in the vaccine are.
means that the girls now - in Germany as a free performance of the health insurance - against all strains of HPV for the prevention of cervical Karznom later - will be vaccinated, treated with highly active biochemical substances that were previously only in the laboratory were tested on animals and their function and compatibility.
And not even these tests are publicly nachlesbar in the databases.
had in the product insert from the market leader Gardasil information be included that have occurred in 2.3 percent of study participants during the observation period of approximately two years, "new diseases, at the behest of the U.S. FDA in December 2008 that may indicate a systemic autoimmune disorder. "In Europe, this note is missing from the vaccine education.
I have in this matter both required to STIKO and the competent Paul-Ehrlich Institute turned and education, as the get recommendation or approval of these vaccines could. Despite the lack of safety studies, despite an alarming study results.
I have received no response. The heads of the Austrian regulatory authorities knew not even on my question about this that it is in at the the HPV vaccine effective amplifiers to novel aluminum compounds acted.
share probably they all have the idea that the Viennese Impfexperte Wolfgang Maurer to me recently represented publicly: meet (company-internal, often not publicly published) laboratory experiments and animal studies to vaccines en masse with novel mode amplifiers use in healthy girls and young women.
safety tests on humans? - No way!
That would probably be too risky for the company, because there could be yes - at risk a billion dollar business - over the investigation of the specific risk!
Impfexperten Our entire bureaucracy seems to make believe that this health risk but should better take the vaccine.
